Tb control in india

Priyamadhaba Behera
Priyamadhaba Beherajunior resident aiims
Epidemiology and Evolving
strategies of TB Control in India
           17/04/2013




        Dr. Priyamadhaba Behera
         Junior Resident, AIIMS
                                    1
Outline of presentation
• Epidemiology
• Evolving strategies of TB Control in India
1.National Tuberculosis Programme (NTP)
2.RNTCP phase I
3.RNTCP phase II
4.STOP TB strategy
5.Universal Access to TB Care
6.National Strategic Plan (2012-2017)
Epidemiology

TB is an infectious disease caused by the bacillus
Mycobacterium tuberculosis

It typically affects the lungs (pulmonary TB) but can affect
other sites as well (extrapulmonary TB)

The disease is spread in the air when people who are sick
with pulmonary TB expel bacteria, for example by coughing

In general, a relatively small proportion of people infected
with Mycobacterium tuberculosis will develop TB disease
Continued
• TB is also more common among men than
  women, and affects mostly adults in the
  economically productive age groups
• Risk factors-
• Biomedical- HIV, DM, silicosis, malnutrition,
  malignancy, tobacco
• Environmental-ventilation, indoor air pollution
• Socioeconomic –crowding, urbanisation, poverty,
  migration
Continued
• Without treatment, mortality rates are high. In studies of
  the natural history of the disease among sputum smear-
  positive and HIV-negative cases of pulmonary TB, around
  70% died within 10 years; among culture-positive (but
  smear-negative) cases, 20% died within 10 years

• The World Health Organization (WHO) declared TB a
  global public health emergency in 1993

• 9 million new cases in 2011 and 1.4 million TB deaths
  (990 000 among HIV negative people and 430 000 HIV-
  associated TB deaths)
Annual risk of infection
• ARI is the most informative index of magnitude of
  problem of tuberculosis
• For ARI=1%
  1. new Smear positive cases=50/lakh/year
  2. new Smear negative cases=50/lakh/year
  3. Retreatment cases=50% new smear positive
     (25/lakh/year)
  4. Extrapulmonary and smear negative seriously ill=20% of
     new smear positive (10/lakh/year)
  5. Total=135/lakh/year
• ARI for India 1-2%
Continued
Continued




In India 2deaths occur in every 3minute due to TB
Tb control in india
Globally, 3.7% (2.1–5.2%) of new cases and
           20% (13–26%) of previously treated cases
           are estimated to have MDR-TB.




IN INDIA                       IN WORLD
Tb control in india
Tb control in india
Tb control in india
Evolution of TB Control in India

• 1962                National TB Programme (NTP)
• 1992                Programme Review
                »   only 30% of patients diagnosed;
                »   of these, only 30% treated successfully
•   1993              RNTCP pilot began
•   1997              RNTCP large scale-implementation
•   2002              700 million population covered
•   2004              >80% of country covered
•   2006              Entire country covered by RNTCP/STOP TB strategy
•   2010              Universal Access to TB Care
•   2012-2017         National Strategic Plan
National Tuberculosis Programme
                          (NTP)
•     India has had a National Tuberculosis Programme (NTP) in place since 1962
•      The treatment success rates were unacceptably low and the death & default
      rates remained high
•     HIV-AIDS epidemic and the spread of multi-drug resistance TB were
      threatening to further worsen the situation.
•     In 1992, GOI, with WHO and SIDA reviewed the TB situation and the following
      were concluded:




    In order to overcome these lacunae, the Government decided to give a new thrust to TB
    control activities by revitalising the NTP, with assistance from international agencies, in
    1993
Revised National TB Control Program
                                 (RNTCP)
•   Pilots were conducted between 1993- 1995 to test the operational
    feasibility in a population of 2.35 million in 5 pilot sites in the states
    of Delhi, Kerala, Gujarat, Maharashtra and West Bengal
•   success of these pilot sites, the programme was expanded to a
    population of 13.85 million in 1995 and 20 million in 1996
•    Large-scale implementation of the RNTCP began in 1997, following
    the successful negotiation of a World Bank credit of US$ 142 million
•    The initial 5-year project plan was to implement the RNTCP in 102
    districts of the country and strengthen another 203 Short Course
    Chemotherapy (SCC) districts for introduction of the revised strategy
    at a later stage.

•      In early 2002, the World Bank assisted TB control project
Revised National TB Control Program
                             (RNTCP)

• Launched in 1997 based on WHO DOTS Strategy
  – Entire country covered in March’06 through an unprecedented
    rapid expansion of DOTS

• Implemented as 100% centrally sponsored
  program
  – Govt. of India is committed to continue the support till TB ceases
    to be a public health problem in the country
Objectives of RNTCP


• To achieve and maintain a cure rate of at
  least 85% among newly detected infectious
  (new sputum smear positive) cases


• To achieve and maintain detection of at least
  70% of such cases in the population
Strategy

1. Augmentation of organizational support at the
   central and state level for meaningful
   coordination
2. Increase in budgetary outlay
3. Use of Sputum microscopy as a primary method
   of diagnosis among self reporting patients
4. Standardized treatment regimens.
contd.

5 Augmentation of the peripheral level supervision
   through the creation of a sub district supervisory
   unit
6 Ensuring a regular uninterrupted supply of drugs
   up to the most peripheral level
7 Emphasis on training, IEC, operational research
   and NGO involvement in the program
Core elements of Phase I

• The core element of RNTCP in Phase I (1997-2006)was to
  ensure high quality DOTS expansion in the country,
  addressing the five primary components of the DOTS
  strategy
RNTCP Phase II( 2006-11)
       Consolidate the achievements of phase I
          Maintain its progressive trend and effect
         further improvement in its functioning
 MPLEMENTATIOIN OF DOTS-PLUS FOR MDR-TB CASES IN A
  PHASED MANNER

 DISRIBUTION OF PAEDIATRIC DRUG BOXES

 INSTITUTIONAL STRENGHTHENING AT NATIONAL, STATE AND
  DISTRICT LEVEL

 INTRODUCTION OF TB-HIV CO-ORDINATOR ,URBAN CO-
  ORDINATOR AND COMMUNICATION FACILITATOR.
STOP TB STRATEGY
•   In 2006, STOP TB strategy was announced by WHO and adopted by RNTCP
•    Many of the National Airborne Infection Control guidelines, developing and
    piloting strategy for 'Practical Approach to Lung Health' are the examples of
    initiatives taken by RNTCP under the comprehensive strategy of STOP TB
Tb control in india
Universal Access to TB Care

•   The twin objectives of 70/85 alone is not enough to achieve adequate
    reduction of TB transmission and reduction in disease with which
    epidemiological impact is expected.
•    RNTCP defined newer objectives of 'Universal Access to TB Care' for TB
    control in India in 2010
•   All TB patients in the community to have access to early, good quality
    diagnosis and treatment services in a manner that is affordable and
    convenient to the patient in time, place and person
•   All affected communities must have full access to TB prevention, care
    and treatment, including women, children, elderly, migrants, homeless
    people, alcohol and other drug users, prison inmates, people living with
    HIV and other clinical risk factors, and those with other life-threatening
    diseases
Specific actions to achieve early and complete case
     detection, towards universal access to TB diagnosis
•    Improve suspects identification
•    Follow up of the sputum negative symptomatic
•    Reduce initial defaulters
•    Screening for TB among high risk groups
1.    HIV
2.    Diabetic patients
3.   Elderly
4.    Smokers
5.    Malnutrition, patients with silicosis and other chronic diseases
Universal access to TB care in Medical Colleges
-------Improve the TB notification system by registering all cases treated under
DOTS and non-DOTS (irrespective of the source of drugs and the regimen used)
in the RNTCP TB register.


------ Conduct operational research to identify local barriers to early case
detection,including care seeking behavior, missed opportunities for diagnosis,
etc.

 -----Collaborate with the local authorities to implement pharmacovigilance for
   anti-TB drugs sold in the district/state with a view to develop locally
innovative
strategies for improvements in notification of TB cases and promotion of
rational use of drugs.
Tb control in india
National Strategic Plan (2012-
                 2017)
12th Five Year Plan: RNTCP has developed
  National Strategic Plan to be implemented
  during 2012-2017

Vision: "TB-free India“

Goal: Universal Access to quality TB diagnosis &
 treatment for all pulmonary & extra pulmonary
 TB patients including drug resistant and HIV
 associated TB.
Objectives

• To achieve 90% notification rate for all types of
  TB cases
• To achieve 90% success rate for all new and 85%
  for re-treatment cases
• To significantly improve the successful outcomes
  of treatment of Drug Resistant TB
• To achieve decreased morbidity and mortality
  of HIV associated TB
• To improve outcomes of TB care in the private
  sector
AREAS
• Strengthening and improving the quality of basic
   DOTS services
• Further strengthen and align with health system under
  NRHM
• Deploying improved rapid diagnosis at the field level
• Expand efforts to engage all care providers
• Strengthen urban TB Control
• Expand diagnosis and treatment of drug resistant TB
• Improve communication and outreach
• Promote research for development and
  implementation of improved tools and strategies
Tb control in india
Tb control in india
1 von 34

Recomendados

NTEP (National Tuberculosis Elimination Programme).pptx von
NTEP (National Tuberculosis Elimination Programme).pptxNTEP (National Tuberculosis Elimination Programme).pptx
NTEP (National Tuberculosis Elimination Programme).pptxImmanuel Joshua
20.2K views36 Folien
Npcdcs von
NpcdcsNpcdcs
NpcdcsDoc Santosh Soren
29.4K views26 Folien
National Vector Borne Disease Control Programme (NVBDCP) von
 National Vector Borne Disease Control Programme (NVBDCP) National Vector Borne Disease Control Programme (NVBDCP)
National Vector Borne Disease Control Programme (NVBDCP)Mr. Kailash Nagar
57.8K views112 Folien
Tuberculosis in india von
Tuberculosis in indiaTuberculosis in india
Tuberculosis in indiaSahdev Bishnoi
1.5K views52 Folien
NPCDCS-INDIA von
NPCDCS-INDIANPCDCS-INDIA
NPCDCS-INDIAMAHESWARI JAIKUMAR
22.2K views26 Folien

Más contenido relacionado

Was ist angesagt?

National Vector Borne Disease Control Programme von
National Vector Borne Disease Control ProgrammeNational Vector Borne Disease Control Programme
National Vector Borne Disease Control ProgrammeDr Lipilekha Patnaik
38.8K views38 Folien
National health programes for non communicable disease von
National health programes for non communicable diseaseNational health programes for non communicable disease
National health programes for non communicable diseaseDr Khyati Boriya -BDS (MHA)
20.7K views59 Folien
National Program for Prevention and Control of Cancer, Diabetes, CVD and Stro... von
National Program for Prevention and Control of Cancer, Diabetes, CVD and Stro...National Program for Prevention and Control of Cancer, Diabetes, CVD and Stro...
National Program for Prevention and Control of Cancer, Diabetes, CVD and Stro...Vivek Varat
13.5K views23 Folien
Rntcp and national strategic plan(nsp) for tb von
Rntcp and national strategic plan(nsp) for tbRntcp and national strategic plan(nsp) for tb
Rntcp and national strategic plan(nsp) for tbWal
23.3K views86 Folien
Revised National Tuberculosis Control Program von
Revised National Tuberculosis Control ProgramRevised National Tuberculosis Control Program
Revised National Tuberculosis Control ProgramAmol Kinge
3.3K views33 Folien
Tb programme von
Tb programmeTb programme
Tb programmefrank jc
17.1K views55 Folien

Was ist angesagt?(20)

National Program for Prevention and Control of Cancer, Diabetes, CVD and Stro... von Vivek Varat
National Program for Prevention and Control of Cancer, Diabetes, CVD and Stro...National Program for Prevention and Control of Cancer, Diabetes, CVD and Stro...
National Program for Prevention and Control of Cancer, Diabetes, CVD and Stro...
Vivek Varat 13.5K views
Rntcp and national strategic plan(nsp) for tb von Wal
Rntcp and national strategic plan(nsp) for tbRntcp and national strategic plan(nsp) for tb
Rntcp and national strategic plan(nsp) for tb
Wal 23.3K views
Revised National Tuberculosis Control Program von Amol Kinge
Revised National Tuberculosis Control ProgramRevised National Tuberculosis Control Program
Revised National Tuberculosis Control Program
Amol Kinge3.3K views
Tb programme von frank jc
Tb programmeTb programme
Tb programme
frank jc17.1K views
Revised national tuberculosis control programme von Ravi Rohilla
Revised national tuberculosis control programmeRevised national tuberculosis control programme
Revised national tuberculosis control programme
Ravi Rohilla40.8K views
Primary health care von drjagannath
Primary health carePrimary health care
Primary health care
drjagannath30.3K views
Epidemiology & prevention of tuberculosis von Dr.Hemant Kumar
Epidemiology & prevention of tuberculosisEpidemiology & prevention of tuberculosis
Epidemiology & prevention of tuberculosis
Dr.Hemant Kumar78.1K views
National Leprosy Eradication Programme (NLEP) von Sneha Gaurkar
National Leprosy Eradication Programme (NLEP)National Leprosy Eradication Programme (NLEP)
National Leprosy Eradication Programme (NLEP)
Sneha Gaurkar1.2K views
Epidemiology of hypertension von Dr.Hemant Kumar
Epidemiology of hypertensionEpidemiology of hypertension
Epidemiology of hypertension
Dr.Hemant Kumar31.7K views
National health policy 2017 new von swati shikha
National health policy 2017 newNational health policy 2017 new
National health policy 2017 new
swati shikha56.1K views
Health programmes in india von SREESHNAKC
Health programmes in indiaHealth programmes in india
Health programmes in india
SREESHNAKC7.3K views
National aids control programme von Immanuel Joshua
National aids control programmeNational aids control programme
National aids control programme
Immanuel Joshua1.9K views

Destacado

Tuberculosis von
Tuberculosis Tuberculosis
Tuberculosis Krunal Goyani
67K views56 Folien
Rntcp current guidelines von
Rntcp current guidelinesRntcp current guidelines
Rntcp current guidelinesDaniel Augustine
11.5K views49 Folien
Presentation – Moving towards TB elimination, 1st Eastern Partnership Ministe... von
Presentation – Moving towards TB elimination, 1st Eastern Partnership Ministe...Presentation – Moving towards TB elimination, 1st Eastern Partnership Ministe...
Presentation – Moving towards TB elimination, 1st Eastern Partnership Ministe...WHO Regional Office for Europe
1.5K views9 Folien
20170304 주일예배, 눅08장40 52절, 옷자락으로 전해진 사랑 - 예배 von
20170304 주일예배, 눅08장40 52절, 옷자락으로 전해진 사랑 - 예배20170304 주일예배, 눅08장40 52절, 옷자락으로 전해진 사랑 - 예배
20170304 주일예배, 눅08장40 52절, 옷자락으로 전해진 사랑 - 예배Myoung-Ryun Mission Presbyterian Church
198 views99 Folien
RNTCP von
RNTCP RNTCP
RNTCP Dr. J.P. Rajliwal
12.3K views60 Folien
CAUSES OF TUBERCULOSIS POWERPOINT von
CAUSES OF TUBERCULOSIS POWERPOINTCAUSES OF TUBERCULOSIS POWERPOINT
CAUSES OF TUBERCULOSIS POWERPOINTnjlarch9
21.5K views10 Folien

Destacado(9)

20170304 주일예배, 눅08장40 52절, 옷자락으로 전해진 사랑 - 예배 von Myoung-Ryun Mission Presbyterian Church
20170304 주일예배, 눅08장40 52절, 옷자락으로 전해진 사랑 - 예배20170304 주일예배, 눅08장40 52절, 옷자락으로 전해진 사랑 - 예배
20170304 주일예배, 눅08장40 52절, 옷자락으로 전해진 사랑 - 예배
CAUSES OF TUBERCULOSIS POWERPOINT von njlarch9
CAUSES OF TUBERCULOSIS POWERPOINTCAUSES OF TUBERCULOSIS POWERPOINT
CAUSES OF TUBERCULOSIS POWERPOINT
njlarch921.5K views
REVISED NATIONAL TUBERCULOSIS CONTROL PROGRAMME (RNTCP) von Vivek Varat
REVISED NATIONAL TUBERCULOSIS CONTROL PROGRAMME (RNTCP)REVISED NATIONAL TUBERCULOSIS CONTROL PROGRAMME (RNTCP)
REVISED NATIONAL TUBERCULOSIS CONTROL PROGRAMME (RNTCP)
Vivek Varat 39.3K views
WHO and RNTCP guidelines - Tuberculosis management von Dr. Pratyush Kumar
WHO and RNTCP guidelines - Tuberculosis managementWHO and RNTCP guidelines - Tuberculosis management
WHO and RNTCP guidelines - Tuberculosis management
Dr. Pratyush Kumar51.3K views
Tuberculosis presentation von RRR784
Tuberculosis presentationTuberculosis presentation
Tuberculosis presentation
RRR784126.3K views

Similar a Tb control in india

cessation of smocking (2).pptx von
cessation of smocking (2).pptxcessation of smocking (2).pptx
cessation of smocking (2).pptxAshraf Shaik
6 views71 Folien
RNTCP von
RNTCPRNTCP
RNTCPNisha Yadav
1.2K views121 Folien
Reasons for innovations and changing strategies in RNTCP 2019 von
Reasons for innovations and changing strategies in RNTCP 2019Reasons for innovations and changing strategies in RNTCP 2019
Reasons for innovations and changing strategies in RNTCP 2019Drsadhana Meena
254 views36 Folien
critical review_RNTCP1 - von
critical review_RNTCP1 -critical review_RNTCP1 -
critical review_RNTCP1 -Isha Porwal
828 views17 Folien
RNTCP ARPIT.pptx von
RNTCP ARPIT.pptxRNTCP ARPIT.pptx
RNTCP ARPIT.pptxArpitChaudhary46
70 views38 Folien
ntep.pptx von
ntep.pptxntep.pptx
ntep.pptxDr. Nishant Mishra
10 views37 Folien

Similar a Tb control in india(20)

cessation of smocking (2).pptx von Ashraf Shaik
cessation of smocking (2).pptxcessation of smocking (2).pptx
cessation of smocking (2).pptx
Ashraf Shaik6 views
Reasons for innovations and changing strategies in RNTCP 2019 von Drsadhana Meena
Reasons for innovations and changing strategies in RNTCP 2019Reasons for innovations and changing strategies in RNTCP 2019
Reasons for innovations and changing strategies in RNTCP 2019
Drsadhana Meena254 views
critical review_RNTCP1 - von Isha Porwal
critical review_RNTCP1 -critical review_RNTCP1 -
critical review_RNTCP1 -
Isha Porwal828 views
Tuberculosis National Health Program in Nepal von Public Health
Tuberculosis National Health Program  in Nepal Tuberculosis National Health Program  in Nepal
Tuberculosis National Health Program in Nepal
Public Health 1.2K views
National Tuberculosis Elimination Programme.pptx von DarshnaSarvaiya2
National Tuberculosis Elimination Programme.pptxNational Tuberculosis Elimination Programme.pptx
National Tuberculosis Elimination Programme.pptx
DarshnaSarvaiya2678 views
Revised national tuberculosis control programme von Mohammed Shafeeqe
Revised national tuberculosis control programmeRevised national tuberculosis control programme
Revised national tuberculosis control programme
Revised National Tuberculosis Control Programme von shayonisen2012
Revised National Tuberculosis Control ProgrammeRevised National Tuberculosis Control Programme
Revised National Tuberculosis Control Programme
shayonisen20122.2K views
Revised National Tuberculosis Control Program- Dr. Atul MD, PGIMER von Yogesh Arora
Revised National Tuberculosis Control Program- Dr. Atul MD, PGIMERRevised National Tuberculosis Control Program- Dr. Atul MD, PGIMER
Revised National Tuberculosis Control Program- Dr. Atul MD, PGIMER
Yogesh Arora584 views
National health programm von Purvi Patel
National health programmNational health programm
National health programm
Purvi Patel2.5K views

Más de Priyamadhaba Behera

Cancer registration and challenges in india von
Cancer registration and challenges in indiaCancer registration and challenges in india
Cancer registration and challenges in indiaPriyamadhaba Behera
8.2K views57 Folien
DISTRICT HEALTH ACTION PLAN von
DISTRICT HEALTH ACTION PLANDISTRICT HEALTH ACTION PLAN
DISTRICT HEALTH ACTION PLANPriyamadhaba Behera
8.3K views42 Folien
Enteric fever von
Enteric feverEnteric fever
Enteric feverPriyamadhaba Behera
5.5K views21 Folien
Hepatitis A von
Hepatitis A Hepatitis A
Hepatitis A Priyamadhaba Behera
29.7K views23 Folien
Cholera von
CholeraCholera
CholeraPriyamadhaba Behera
24.4K views44 Folien
Malaria control strategies in india von
Malaria control strategies in indiaMalaria control strategies in india
Malaria control strategies in indiaPriyamadhaba Behera
26.1K views54 Folien

Último

melani glossophobia.pdf von
melani glossophobia.pdfmelani glossophobia.pdf
melani glossophobia.pdfPaygeon
9 views1 Folie
Depression PPT template von
Depression PPT templateDepression PPT template
Depression PPT templateEmanMegahed6
19 views36 Folien
Epileptogenesis von
EpileptogenesisEpileptogenesis
EpileptogenesisVamsi Krishna Koneru
9 views50 Folien
CAPSULE von
 CAPSULE CAPSULE
CAPSULEGanapathi Vankudoth
62 views24 Folien
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (... von
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...PeerVoice
7 views23 Folien
Top PCD Pharma Franchise Companies in India | Saphnix Lifesciences von
Top PCD Pharma Franchise Companies in India | Saphnix LifesciencesTop PCD Pharma Franchise Companies in India | Saphnix Lifesciences
Top PCD Pharma Franchise Companies in India | Saphnix LifesciencesSaphnix Lifesciences
25 views11 Folien

Último(20)

melani glossophobia.pdf von Paygeon
melani glossophobia.pdfmelani glossophobia.pdf
melani glossophobia.pdf
Paygeon9 views
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (... von PeerVoice
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...
PeerVoice7 views
Top PCD Pharma Franchise Companies in India | Saphnix Lifesciences von Saphnix Lifesciences
Top PCD Pharma Franchise Companies in India | Saphnix LifesciencesTop PCD Pharma Franchise Companies in India | Saphnix Lifesciences
Top PCD Pharma Franchise Companies in India | Saphnix Lifesciences
Top 10 Pharma Companies in Mumbai | Medibyte von Medibyte Pharma
Top 10 Pharma Companies in Mumbai | MedibyteTop 10 Pharma Companies in Mumbai | Medibyte
Top 10 Pharma Companies in Mumbai | Medibyte
Medibyte Pharma17 views
MEDICAL RESEARCH.pptx von rishi2789
MEDICAL RESEARCH.pptxMEDICAL RESEARCH.pptx
MEDICAL RESEARCH.pptx
rishi278948 views
Peptic ulcer.pdf von UVAS
Peptic ulcer.pdfPeptic ulcer.pdf
Peptic ulcer.pdf
UVAS7 views
Complications & Solutions in Laparoscopic Hernia Surgery.pptx von Varunraju9
Complications & Solutions in Laparoscopic Hernia Surgery.pptxComplications & Solutions in Laparoscopic Hernia Surgery.pptx
Complications & Solutions in Laparoscopic Hernia Surgery.pptx
Varunraju9106 views
Structural Racism and Public Health: How to Talk to Policymakers and Communit... von katiequigley33
Structural Racism and Public Health: How to Talk to Policymakers and Communit...Structural Racism and Public Health: How to Talk to Policymakers and Communit...
Structural Racism and Public Health: How to Talk to Policymakers and Communit...
katiequigley33627 views
Blockchain based automatic diagnosis of the 12-lead ECG using a deep neural n... von RajaulKarim20
Blockchain based automatic diagnosis of the 12-lead ECG using a deep neural n...Blockchain based automatic diagnosis of the 12-lead ECG using a deep neural n...
Blockchain based automatic diagnosis of the 12-lead ECG using a deep neural n...
RajaulKarim2099 views

Tb control in india

  • 1. Epidemiology and Evolving strategies of TB Control in India 17/04/2013 Dr. Priyamadhaba Behera Junior Resident, AIIMS 1
  • 2. Outline of presentation • Epidemiology • Evolving strategies of TB Control in India 1.National Tuberculosis Programme (NTP) 2.RNTCP phase I 3.RNTCP phase II 4.STOP TB strategy 5.Universal Access to TB Care 6.National Strategic Plan (2012-2017)
  • 3. Epidemiology TB is an infectious disease caused by the bacillus Mycobacterium tuberculosis It typically affects the lungs (pulmonary TB) but can affect other sites as well (extrapulmonary TB) The disease is spread in the air when people who are sick with pulmonary TB expel bacteria, for example by coughing In general, a relatively small proportion of people infected with Mycobacterium tuberculosis will develop TB disease
  • 4. Continued • TB is also more common among men than women, and affects mostly adults in the economically productive age groups • Risk factors- • Biomedical- HIV, DM, silicosis, malnutrition, malignancy, tobacco • Environmental-ventilation, indoor air pollution • Socioeconomic –crowding, urbanisation, poverty, migration
  • 5. Continued • Without treatment, mortality rates are high. In studies of the natural history of the disease among sputum smear- positive and HIV-negative cases of pulmonary TB, around 70% died within 10 years; among culture-positive (but smear-negative) cases, 20% died within 10 years • The World Health Organization (WHO) declared TB a global public health emergency in 1993 • 9 million new cases in 2011 and 1.4 million TB deaths (990 000 among HIV negative people and 430 000 HIV- associated TB deaths)
  • 6. Annual risk of infection • ARI is the most informative index of magnitude of problem of tuberculosis • For ARI=1% 1. new Smear positive cases=50/lakh/year 2. new Smear negative cases=50/lakh/year 3. Retreatment cases=50% new smear positive (25/lakh/year) 4. Extrapulmonary and smear negative seriously ill=20% of new smear positive (10/lakh/year) 5. Total=135/lakh/year • ARI for India 1-2%
  • 8. Continued In India 2deaths occur in every 3minute due to TB
  • 10. Globally, 3.7% (2.1–5.2%) of new cases and 20% (13–26%) of previously treated cases are estimated to have MDR-TB. IN INDIA IN WORLD
  • 14. Evolution of TB Control in India • 1962 National TB Programme (NTP) • 1992 Programme Review » only 30% of patients diagnosed; » of these, only 30% treated successfully • 1993 RNTCP pilot began • 1997 RNTCP large scale-implementation • 2002 700 million population covered • 2004 >80% of country covered • 2006 Entire country covered by RNTCP/STOP TB strategy • 2010 Universal Access to TB Care • 2012-2017 National Strategic Plan
  • 15. National Tuberculosis Programme (NTP) • India has had a National Tuberculosis Programme (NTP) in place since 1962 • The treatment success rates were unacceptably low and the death & default rates remained high • HIV-AIDS epidemic and the spread of multi-drug resistance TB were threatening to further worsen the situation. • In 1992, GOI, with WHO and SIDA reviewed the TB situation and the following were concluded: In order to overcome these lacunae, the Government decided to give a new thrust to TB control activities by revitalising the NTP, with assistance from international agencies, in 1993
  • 16. Revised National TB Control Program (RNTCP) • Pilots were conducted between 1993- 1995 to test the operational feasibility in a population of 2.35 million in 5 pilot sites in the states of Delhi, Kerala, Gujarat, Maharashtra and West Bengal • success of these pilot sites, the programme was expanded to a population of 13.85 million in 1995 and 20 million in 1996 • Large-scale implementation of the RNTCP began in 1997, following the successful negotiation of a World Bank credit of US$ 142 million • The initial 5-year project plan was to implement the RNTCP in 102 districts of the country and strengthen another 203 Short Course Chemotherapy (SCC) districts for introduction of the revised strategy at a later stage. • In early 2002, the World Bank assisted TB control project
  • 17. Revised National TB Control Program (RNTCP) • Launched in 1997 based on WHO DOTS Strategy – Entire country covered in March’06 through an unprecedented rapid expansion of DOTS • Implemented as 100% centrally sponsored program – Govt. of India is committed to continue the support till TB ceases to be a public health problem in the country
  • 18. Objectives of RNTCP • To achieve and maintain a cure rate of at least 85% among newly detected infectious (new sputum smear positive) cases • To achieve and maintain detection of at least 70% of such cases in the population
  • 19. Strategy 1. Augmentation of organizational support at the central and state level for meaningful coordination 2. Increase in budgetary outlay 3. Use of Sputum microscopy as a primary method of diagnosis among self reporting patients 4. Standardized treatment regimens.
  • 20. contd. 5 Augmentation of the peripheral level supervision through the creation of a sub district supervisory unit 6 Ensuring a regular uninterrupted supply of drugs up to the most peripheral level 7 Emphasis on training, IEC, operational research and NGO involvement in the program
  • 21. Core elements of Phase I • The core element of RNTCP in Phase I (1997-2006)was to ensure high quality DOTS expansion in the country, addressing the five primary components of the DOTS strategy
  • 22. RNTCP Phase II( 2006-11) Consolidate the achievements of phase I Maintain its progressive trend and effect further improvement in its functioning  MPLEMENTATIOIN OF DOTS-PLUS FOR MDR-TB CASES IN A PHASED MANNER  DISRIBUTION OF PAEDIATRIC DRUG BOXES  INSTITUTIONAL STRENGHTHENING AT NATIONAL, STATE AND DISTRICT LEVEL  INTRODUCTION OF TB-HIV CO-ORDINATOR ,URBAN CO- ORDINATOR AND COMMUNICATION FACILITATOR.
  • 23. STOP TB STRATEGY • In 2006, STOP TB strategy was announced by WHO and adopted by RNTCP • Many of the National Airborne Infection Control guidelines, developing and piloting strategy for 'Practical Approach to Lung Health' are the examples of initiatives taken by RNTCP under the comprehensive strategy of STOP TB
  • 25. Universal Access to TB Care • The twin objectives of 70/85 alone is not enough to achieve adequate reduction of TB transmission and reduction in disease with which epidemiological impact is expected. • RNTCP defined newer objectives of 'Universal Access to TB Care' for TB control in India in 2010 • All TB patients in the community to have access to early, good quality diagnosis and treatment services in a manner that is affordable and convenient to the patient in time, place and person • All affected communities must have full access to TB prevention, care and treatment, including women, children, elderly, migrants, homeless people, alcohol and other drug users, prison inmates, people living with HIV and other clinical risk factors, and those with other life-threatening diseases
  • 26. Specific actions to achieve early and complete case detection, towards universal access to TB diagnosis • Improve suspects identification • Follow up of the sputum negative symptomatic • Reduce initial defaulters • Screening for TB among high risk groups 1. HIV 2. Diabetic patients 3. Elderly 4. Smokers 5. Malnutrition, patients with silicosis and other chronic diseases
  • 27. Universal access to TB care in Medical Colleges
  • 28. -------Improve the TB notification system by registering all cases treated under DOTS and non-DOTS (irrespective of the source of drugs and the regimen used) in the RNTCP TB register. ------ Conduct operational research to identify local barriers to early case detection,including care seeking behavior, missed opportunities for diagnosis, etc. -----Collaborate with the local authorities to implement pharmacovigilance for anti-TB drugs sold in the district/state with a view to develop locally innovative strategies for improvements in notification of TB cases and promotion of rational use of drugs.
  • 30. National Strategic Plan (2012- 2017) 12th Five Year Plan: RNTCP has developed National Strategic Plan to be implemented during 2012-2017 Vision: "TB-free India“ Goal: Universal Access to quality TB diagnosis & treatment for all pulmonary & extra pulmonary TB patients including drug resistant and HIV associated TB.
  • 31. Objectives • To achieve 90% notification rate for all types of TB cases • To achieve 90% success rate for all new and 85% for re-treatment cases • To significantly improve the successful outcomes of treatment of Drug Resistant TB • To achieve decreased morbidity and mortality of HIV associated TB • To improve outcomes of TB care in the private sector
  • 32. AREAS • Strengthening and improving the quality of basic DOTS services • Further strengthen and align with health system under NRHM • Deploying improved rapid diagnosis at the field level • Expand efforts to engage all care providers • Strengthen urban TB Control • Expand diagnosis and treatment of drug resistant TB • Improve communication and outreach • Promote research for development and implementation of improved tools and strategies

Hinweis der Redaktion

  1. Population Attributable Fraction (PAF) Quantifying the contribution of risk factors to the Burden of Disease Definition The contribution of a risk factor to a disease or a death is quantified using the population attributable fraction (PAF). PAF is the proportional reduction in population disease or mortality that would occur if exposure to a risk factor were reduced to an alternative ideal exposure scenario (eg. no tobacco use). Many diseases are caused by multiple risk factors, and individual risk factors may interact in their impact on overall risk of disease. As a result, PAFs for individual risk factors often overlap and add up to more than 100 percent. Calculating PAF Pi = proportion of population at exposure level i, current exposure P'i = proportion of population at exposure level i, counterfactual or ideal level of exposure RR = the relative risk at exposure level i n = the number of exposure levels For risk factors with continuous rather than discrete exposure levels there is an analogous formula for PAF involving integration of the exposure level distribution.
  2. Extensively drug resistant TB (XDR-TB), subset of MDR-TB with resistance to second line drugs i.e. any fluoroquinolone and to at least 1 of the 3 second line injectable drugs (capreomycin, kanamycin and amikacin), To obtain a more precise estimate of Multi-Drug ResistantTB (MDR-TB) burden in the country, RNTCP carried out drug resistance surveillance (DRS) surveys in accordance with global guidelines in selected states, Gujarat (56 million population) and Maharashtra (107 million) in 2005-2006 and Andhra Pradesh (81 million) in 2007-2008. The results of these surveys indicate prevalence of MDR-TB to be low i.e. less than 3% amongst new cases and 12-17% in re-treatment cases
  3. Swedish International Development Cooperation Agency ( SIDA ), Government of India
  4. Sputum microscopy continues to be the primary tool for detection of infectious cases. Apart from sputum microscopy, RNTCP also uses standardized diagnostic algorithms to diagnose and treat all forms of TB wherein X-ray plays a supporting role. However in line with the stop TB strategy the program is exploring all possible avenues with newer and innovative technologies for early detection of TB including use of LED fluorescent microscopes, liquid culture and line probe assay for diagnosis drug resistant TB etc. Sufficient anti-TB drugs in patient wise boxes are made available at all the appropriate levels (Peripheral Health Institution/TB unit/District/State/National). The uninterrupted supply of drugs to teach patient is made possible through the “patient wise box.” Patient-wise drug boxes (both adult and pediatric) are an innovation of RNTCP wherein a box of medications for the entire duration of the treatment is earmarked for every patient registered. Directly observed treatment (DOT) is one of the key elements of the DOTS strategy. In DOT, an observer (health worker or trained community volunteer who is not a family member) watches and supports the patient in taking drugs. The DOT provider ensures that the patient takes the right drugs, in the right doses, at the right intervals, for the right duration. RNTCP has a systematic monitoring mechanism which accounts for/tracks the outcome of every patient put-on treatment. There is a standardized recording and reporting structure in place. The cure rate and other key indicators are monitored regularly at every level of the health system and regular supervision ensures quality of the program. RNTCP shifts the responsibility for cure from the patient to the health system.
  5. The RNTCP Phase II of the World Bank project has been approved by the CCEA for the period Oct 2006 to Sep 2011 for a total outlay of USD 256.9 million which includes credit from World Bank of USD 170 million and commodity assistance of anti-TB drugs from DFID through WHO for USD 62.5 million, and the balance by GoI. New financial norms in respect of certain expenditure heads have been approved by Cabinet Committee on Economic Affairs which have been implemented with effect from April 01, 2009. Global Fund Support: The Global Fund has supported by grants) DOTS expansion in India under different rounds. DOTS expansion in the 3 States of Chhattisgarh, Jharkhand, and Uttarakhand (56 million populations) was supported by grants for USD 8.78 million under Round 1 of GFATM from April 2003-September 2006. In addition, the Round 2 of GFATM supported DOTS expansion in 56 districts of Bihar and Uttar Pradesh with a population of 110 million for USD 29.10 million (April 2004 to March 2009). Round 4 of GFATM is supporting strengthening of RNTCP implementation in the states of Andhra Pradesh and Orissa w.e.f November 05 and January 2006 respectively for USD 26.63 million till March 2010.
  6. The Practical Approach to Lung Health (PAL) is one of the strategies intended to overcome the challenge posed by weak health systems. This initiative is aimed at managing respiratory patients in primary health care settings while expanding TB detection and good-quality TB services. PAL focuses on the most prevalent respiratory diseases at first-level health facilities – pneumonia, acute bronchitis and other acute respiratory infections, TB, and chronic respiratory conditions including chronic bronchitis, asthma and chronic obstructive pulmonary disease. PAL uses two main approaches to achieve integrated case-management of respiratory patients in primary health care: standardization of diagnosis and treatment of respiratory conditions, and coordination among health workers of different levels.